5.3.24
2024 AD/PD conference
7.11.23
Amyl Therapeutics receives additional €5M funding
4.9.22
Amyl Team at the International Society on amyloidosis
We are proud to announce that the Amyl team participated in the ISA (International Society on Amyloidosis) 2022 conference, presenting a poster that highlights our latest advancements on amyloidosis disease research. The team had the opportunity to engage with leading scientists and industry experts, sharing our insights and learning from the brightest minds in the field.
For those interested in our work, you can download our poster presentation here. We are excited to continue pushing the boundaries of science and look forward to further discussions sparked by our research.